Clinical trials
Active, not recruiting Phase 2 Glioma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 13 |
| Actuate Therapeutics Inc. | 1 |
| Children's Oncology Group | 1 |
| Daiichi Sankyo Co., Ltd. | 1 |
| David W. Roberts | 1 |
| Eli Lilly and Company | 1 |
| NRG Oncology | 1 |
| St. Justine's Hospital | 1 |
| Stony Brook University | 1 |
| University Health Network, Toronto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 22 |
| Lymphoma, Non-Hodgkin | 9 |
| Ependymoma | 8 |
| Hepatoblastoma | 8 |
| Histiocytosis, Langerhans-Cell | 8 |
| Medulloblastoma | 8 |
| Neuroblastoma | 8 |
| Neuroectodermal Tumors, Primitive, Peripheral | 8 |
| Rhabdoid Tumor | 8 |
| Sarcoma | 8 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.